Product Information
NYSTATIN-TRIAMCINOLONE OINTM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2266 per GM under NDC 45802024496. Its NADAC has been published 456 times since Nov 29, 2017.
FDA first approved this application on Dec 20, 2016. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802024496
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207380FDA Approved
12/20/2016
TE Code
AT
On Market Since
10/18/2017
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE OINTM has been published 456 times since Nov 29, 2017, and over the history we have for it it has declined 86.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2266 per GM |
|---|---|
| All-time high | $1.6216 (Dec 13, 2017) |
| All-time low | $0.1662 (Jan 18, 2023) |
| 52-week high | $0.2516 |
| 52-week low | $0.2058 |
| Median price | $0.2828 |
| Average price | $0.3968 |
| Largest weekly change | +73.9% (Mar 20, 2024) |
| Weeks tracked | 456 |
| Tracking since | Nov 29, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE OINTM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE OINTM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2266 per GM (NDC 45802024496), effective Aug 19, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE OINTM changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE OINTM has declined 86.0%. It has been tracked across 456 weekly CMS publications since Nov 29, 2017.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE OINTM?
Since Nov 29, 2017, the NADAC for NYSTATIN-TRIAMCINOLONE OINTM has ranged from a low of $0.1662 (Jan 18, 2023) to a high of $1.6216 (Dec 13, 2017), with a median of $0.2828 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE OINTM?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NYSTATIN-TRIAMCINOLONE OINTM in a comparable dosage form, but none are currently priced below it.
Who manufactures NYSTATIN-TRIAMCINOLONE OINTM?
NYSTATIN-TRIAMCINOLONE OINTM (NDC 45802024496) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.